Department of Drug Administration Notice Regarding Sale and Distribution and Use of Neolore (Lorazepam Inj)
According to the test report obtained from the National Medicine Laboratory of the sample of the medicine collected during the monitoring from Department of Drug Administration – DDA, the medicine as per the details has not been registered in the Department of Drug Administration – DDA so far. Also, as the medicine mentioned in the label of the medicine was not found, the medicine is also counterfeit, so it is requested to inform all concerned not to recommend, sell, distribute and even use the medicine.
- DDA Notice Regarding Recall of Handsanitizer
- DDA Notice Regarding False and Misleading Propaganda of Medicines